Controlling your
type 2 diabetes just
got easier with Revita®.

Revita is a new therapy that addresses a root cause of type 2 diabetes—in your gut.
This non-drug procedure is CE marked. Revita has been shown to reduce the need for insulin in people with T2D who were also prescribed Liraglutide.¹ It is routinely performed in select hospitals in Germany, and is generally covered by public health insurance.*

1. van Baar et al. Gastrointest Endosc. 2021; 94:111-20
*Under the innovation-funding program (§ 137 h SGBV). Revita is clinically evaluated over a period of 5 years.